Promis Neurosciences logo

Promis Neurosciences Share Price Today

(NASDAQ: PMN)

Promis Neurosciences share price is $0.78 & ₹67.84 as on 6 Mar 2025, 2.30 'hrs' IST

$0.78

Market is closed - opens 8 PM, 06 Mar 2025

View live Promis Neurosciences share price in Dollar and Rupees. Guide to invest in Promis Neurosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Promis Neurosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Promis Neurosciences share price movements

  • Today's Low: $0.69
    Today's High: $0.86

    Day's Volatility :19.38%

  • 52 Weeks Low: $0.62
    52 Weeks High: $2.61

    52 Weeks Volatility :76.21%

Promis Neurosciences (PMN) Returns

PeriodPromis Neurosciences IncIndex (Russel 2000)
3 Months
-16.24%
0.0%
6 Months
-43.09%
0.0%
1 Year
-64.59%
0.0%
3 Years
-91.58%
-11.6%

Promis Neurosciences (PMN) Key Statistics

in dollars & INR

Previous Close
$0.779
Open
$0.77
Today's High
$0.86
Today's Low
$0.6933
Market Capitalization
$25.5M
Today's Volume
$579.0
52 Week High
$2.61
52 Week Low
$0.6208
Revenue TTM
$7.6K
EBITDA
$-14.7M
Earnings Per Share (EPS)
$0.04
PE Ratio
19.48
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-8.03%

How to invest in Promis Neurosciences Stock (PMN) from India?

It is very easy for Indian residents to invest directly in Promis Neurosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Promis Neurosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Promis Neurosciences or PMN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Promis Neurosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Promis Neurosciences shares which would translate to 1.115 fractional shares of Promis Neurosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Promis Neurosciences, in just a few clicks!

Returns in Promis Neurosciences (PMN) for Indian investors in Rupees

The Promis Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Promis Neurosciences investment value today

Current value as on today

₹40,417

Returns

₹59,583

(-59.58%)

Returns from Promis Neurosciences Stock

₹64,545 (-64.55%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Promis Neurosciences (PMN)

0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Promis Neurosciences Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Promis Neurosciences

  • Great Point Partners LLC

    8.09%

  • Armistice Capital, LLC

    7.68%

  • Sphera Funds Management Ltd.

    5.90%

  • Ally Bridge Group (NY) LLC

    4.87%

  • Altium Capital Management, LP

    1.78%

  • Allostery Investments LP

    0.60%

Analyst Recommendation on Promis Neurosciences

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 6 Wall street analysts offering stock ratings for Promis Neurosciences(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
4
4
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Promis Neurosciences Stock (PMN)

What analysts predicted

Upside of 883.33%

Target:

$7.67

Current:

$0.78

Insights on Promis Neurosciences Stock (Ticker Symbol: PMN)

  • Price Movement

    In the last 7 days, PMN stock has moved up by 1.2%
  • PMN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 123.7%
  • Price to Sales

    ForPMN every $1 of sales, investors are willing to pay $779.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Promis Neurosciences Technicals Summary

Sell

Neutral

Buy

Promis Neurosciences is currently in a neutral trading position according to technical analysis indicators.

Promis Neurosciences (PMN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Promis Neurosciences Inc logo
-15.28%
-43.09%
-64.59%
-91.58%
-91.58%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Promis Neurosciences Inc logo
19.48
19.48
NA
0.0
-0.08
-0.43
NA
0.22
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Promis Neurosciences Inc logo
Buy
$25.5M
-91.58%
19.48
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Promis Neurosciences

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Organization
Promis Neurosciences
Employees
6
CEO
Mr. Neil K. Warma M.B.A.
Industry
Miscellaneous

Management People of Promis Neurosciences

NameTitle
Mr. Eugene W. Williams
Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.
CEO, President & Director
Dr. Neil R. Cashman M.D.
Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Mr. Daniel E. Geffken M.B.A.
Chief Financial Officer
Dr. Johanne Kaplan Ph.D.
Chief Development Officer
Dr. David Wishart Ph.D.
Chief Physics Officer
Mr. Dennis Chen Ph.D.
Head of Manufacturing & Senior Consultant
Dr. Larry Douglas Altstiel M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in PMN Stock from India :

What is Promis Neurosciences share price today?

Promis Neurosciences share price today stands at $0.78, Open: $0.77 ; Previous Close: $0.78 ; High: $0.86 ; Low: $0.69 ; 52 Week High: $2.61 ; 52 Week Low: $0.62.

The stock opens at $0.77, after a previous close of $0.78. The stock reached a daily high of $0.86 and a low of $0.69, with a 52-week high of $2.61 and a 52-week low of $0.62.

Can Indians buy Promis Neurosciences shares?

Yes, Indians can invest in the Promis Neurosciences (PMN) from India.

With INDmoney, you can buy Promis Neurosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Promis Neurosciences at zero transaction cost.

How can I buy Promis Neurosciences shares from India?

It is very easy to buy Promis Neurosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Promis Neurosciences (PMN) be purchased?

Yes, you can buy fractional shares of Promis Neurosciences with INDmoney app.

What are the documents required to start investing in Promis Neurosciences stocks?

To start investing in Promis Neurosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Promis Neurosciences Stock (PMN)?

Today’s highest price of Promis Neurosciences (PMN) is $0.86.

Today’s lowest price of Promis Neurosciences (PMN) is $0.69.

What is today's market capitalisation of Promis Neurosciences?

Today's market capitalisation of Promis Neurosciences PMN is 25.5M

What is the 52 Week High and Low Range of Promis Neurosciences Stock (PMN)?

  • 52 Week High

    $2.61

  • 52 Week Low

    $0.62

What are the historical returns of Promis Neurosciences (PMN)?

  • 1 Month Returns

    -15.28%

  • 3 Months Returns

    -43.09%

  • 1 Year Returns

    -64.59%

  • 5 Years Returns

    -91.58%

Who is the Chief Executive Officer (CEO) of Promis Neurosciences ?

Mr. Neil K. Warma M.B.A. is the current Chief Executive Officer (CEO) of Promis Neurosciences.